Pulse Biosciences, Inc. Share Price & Technical Analysis
PLSE · $25.89 (+1.29%)
Healthcare / Medical Instruments & Supplies
$25.89
+1.29%
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
22% return in May, 15% avg return in past 3 year May month.
73% return in 2026, 96% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 36% | 20% | -4% | 22% | – | – | – | – | – | – | – | 73% |
| 25 | 20% | -10% | -12% | 6% | -1% | -13% | 0% | 5% | 15% | -4% | -18% | 1% | -11% |
| 24 | -26% | 11% | -14% | -4% | 59% | -3% | 36% | 24% | -5% | -2% | 24% | -19% | 82% |
| 23 | 11% | -16% | 31% | 88% | -13% | 16% | 10% | -40% | -13% | 13% | 100% | 28% | 215% |
| 22 | -18% | -58% | -6% | -40% | -12% | -32% | 0% | -19% | 77% | -9% | -5% | 47% | -73% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.49B
P/E ratio
—
52W high
$27.98
52W low
$12.56
Volume
2,50,593
Beta
1.63
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Pulse Biosciences, Inc. share price today?
- Pulse Biosciences, Inc. (PLSE) last traded around $25.89 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PLSE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PLSE. Download the app for real-time alerts.
- How can I analyze Pulse Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.